Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Tandem Diabetes Care (TNDM) Net Margin (2016 - 2025)

Historic Net Margin for Tandem Diabetes Care (TNDM) over the last 13 years, with Q3 2025 value amounting to 8.48%.

  • Tandem Diabetes Care's Net Margin rose 10500.0% to 8.48% in Q3 2025 from the same period last year, while for Sep 2025 it was 20.2%, marking a year-over-year decrease of 53500.0%. This contributed to the annual value of 10.21% for FY2024, which is 195600.0% up from last year.
  • As of Q3 2025, Tandem Diabetes Care's Net Margin stood at 8.48%, which was up 10500.0% from 21.77% recorded in Q2 2025.
  • In the past 5 years, Tandem Diabetes Care's Net Margin ranged from a high of 5.13% in Q4 2021 and a low of 73.15% during Q1 2023
  • Moreover, its 5-year median value for Net Margin was 9.53% (2024), whereas its average is 15.57%.
  • In the last 5 years, Tandem Diabetes Care's Net Margin crashed by -647800bps in 2023 and then skyrocketed by 508600bps in 2024.
  • Over the past 5 years, Tandem Diabetes Care's Net Margin (Quarter) stood at 5.13% in 2021, then tumbled by -240bps to 7.19% in 2022, then crashed by -112bps to 15.23% in 2023, then soared by 102bps to 0.27% in 2024, then plummeted by -3194bps to 8.48% in 2025.
  • Its last three reported values are 8.48% in Q3 2025, 21.77% for Q2 2025, and 55.71% during Q1 2025.